115370 Results

People

  1. Ladanyi
    Ladanyi
  2. Motzer
    Motzer
  3. Reuter
    Reuter
  4. Scher
    Scher
  5. Brennan
    Brennan
  6. Giralt
    Giralt
  7. Gonen
    Gonen
  8. Perales
    Perales
  9. Hudis
    Hudis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (39031)
  2. GSK Faculty (22466)
  3. Solid Tumor Oncology Division (22055)
  4. Surgery (21246)
  5. Sloan Kettering Institute Faculty (16085)
  6. Survivorship Research (15761)
  7. Center for Hematologic Malignancies (13261)
  8. Hematologic Malignancies, Division of (13086)
  9. Sloan Kettering Institute Postdocs (12935)
  10. Department of Pathology and Laboratory Medicine (12608)
Formats
  1. Journal Article (66746)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3744)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (660)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39031)
  2. GSK Faculty (22466)
  3. Solid Tumor Oncology Division (22055)
  4. Surgery (21246)
  5. Sloan Kettering Institute Faculty (16085)
  6. Survivorship Research (15761)

More Groups

People
  1. Marc Ladanyi (1326)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1049)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5598)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115370)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy and safety of alpelisib plus olaparib versus chemotherapy among patients with platinum-resistant or refractory high-grade serous ovarian cancer without BRCA mutation: Primary analysis of the EPIK-O trial
    Meeting Abstract

    Konstantinopoulos, P.; Kim, J. W.; Freyer, G.; Lee, J. Y.; Gaba, L.; Grisham, R.; Colombo, N.; Wu, X.; Sehouli, J.; Cruz, F.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Sexual function and menopausal symptoms among patients at high risk of ovarian carcinoma undergoing interval salpingectomy or risk-reducing salpingo-oophorectomy in the prospective multicenter WISP trial
    Meeting Abstract

    Norquist, B.; Nebgen, D.; Roche, K. L.; Bakkum-Gamez, J.; Romero, I.; Feltmate, C.; Levine, D.; Kim, S.; Hagemann, A.; Carter, J.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Efficacy and safety of trastuzumab deruxtecan among patients with HER2-expressing solid tumors: Biomarker and subgroup analyses from the cervical, endometrial, and ovarian cancer cohorts of the DESTINY-PanTumor02 study
    Meeting Abstract

    Makker, V.; Oaknin, A.; Manso, L.; González-Martín, A.; Lugowska, I.; Meric-Bernstam, F.; Lorusso, D.; Banerjee, S.; Liao, J.; Siena, S.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Successful implementation of a goals-to-discharge patient checklist following surgery for gynecologic cancer
    Meeting Abstract

    Byrne, M.; Roche, K. L.; Chi, D.; Sonoda, Y.; Abu-Rustum, N.; Gardner, G.; Broach, V.
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • A recovery coefficient model for resolution characterization, harmonization, and shape-specific partial volume correction
    Meeting Abstract

    Marquis, H.; Schmidtlein, C. R.; de Nijs, R.; Mínguez Gabiña, P.; Gustafsson, J. R.; Ocampo Ramos, J. C.; Kayal, G.; Carter, L. M.; Bailey, D. L.; Kesner, A. L.
    European Journal of Nuclear Medicine and Molecular Imaging (2024)

    Fulltext@MSK | Save
  • Tumour dosimetry across 6 cycles of [(177)Lu]LuPSMA-617 in patients with metastatic castrationresistant prostate cancer: Results from the VISION substudy
    Meeting Abstract

    Herrmann, K.; Krause, B.; Chi, K.; Sartor, O.; Fizazi, K.; Morris, M. J.; De Bono, J.; Tagawa, S.; Kurth, J.; Eiber, M.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2024)

    Fulltext@MSK | Save
  • Bone marrow dosimetry exploratory analysis from the phase 3 SIERRA trial of (131)I-apamistamab prior to HCT in relapsed/refractory acute myeloid leukemia
    Meeting Abstract

    Pandit-Taskar, N.; Natwa, M.; Chen, M.; Leung, E.; Spross, J.; Li, K.; Desai, A.; Brodin, P.; Wahl, R.
    European Journal of Nuclear Medicine and Molecular Imaging (2024)

    Fulltext@MSK | Save
  • In-situ (90)Y microdosimetry and biological effects at microscopic level after transarterial radioembolization
    Meeting Abstract

    Kirov, A.; Carter, L.; Talarico, O.; Teplov, A.; Vakiani, E.; Lafontaine, D.; Kunin, H.; Chan, E.; Nehmeh, M.; Dimopoulos, M. P.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2024)

    Fulltext@MSK | Save
  • Targeting fibroblast activation protein using radioactively tagged sibrotuzumab
    Meeting Abstract

    Ingham, A.; De Gregorio, R.; Viray, T.; Loor, A.; Harris, M.; Lewis, J. S.
    European Journal of Nuclear Medicine and Molecular Imaging (2024)

    Fulltext@MSK | Save
  • Development of PET response criteria in neuroendocrine tumors (PERCIN)
    Meeting Abstract

    Chaban, A.; Dinkel, V.; Eiber, M.; Song, Y.; Brosch-Lenz, J.; Krebs, S.; Bodei, L.; Weber, W.
    European Journal of Nuclear Medicine and Molecular Imaging (2024)

    Fulltext@MSK | Save